| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 138,564 | 229,722 | 256,810 | 323,442 | | Cost of Revenue | 114,908 | 161,602 | 200,902 | 224,772 | | | Gross Profit | 23,656 | 68,120 | 55,908 | 98,670 | | | Operating Expenses | | Research Development | 13,887 | 14,759 | 20,943 | 16,052 | | Selling General and Administrative | 54,917 | 62,459 | 80,522 | 88,613 | | Non Recurring |
-
|
-
|
-
| 1,601 | | Others | 4,457 | 4,777 | 5,108 | 5,629 | | | | Total Operating Expenses |
-
|
-
|
-
| 111,895 | | | | Operating Income or Loss | (49,605) | (13,875) | (50,665) | (13,225) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (882) | (1,467) | 2,349 | (296) | | Earnings Before Interest And Taxes | (50,487) | (15,342) | (48,316) | (13,521) | | Interest Expense | 2,310 |
-
|
-
| 3,306 | | Income Before Tax | (52,797) | (15,342) | (48,316) | (16,827) | | Income Tax Expense | 2,675 | (5,262) | 2,072 | (1,873) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (55,472) | (10,080) | (50,388) | (14,954) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (55,472) | (10,080) | (50,388) | (14,954) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($55,472) | ($10,080) | ($50,388) | ($14,954) |
|
0.88% Nasdaq 
0.02 (0.25%) 
Income Statement
